Nevirapine 50mg disp. tabs/PAC-30

Nevirapine 50mg dispersible tablets, bottle pack of 30
Indicative Price : Upon Request
Disclaimer: The images shown are for illustration purposes only and may not be an exact representation of the product. “No Generic Photo Available" means that there is not an image available for this product.

NOTE: The description below is for a standard product. It is not specific to patent status and pricing policies that may apply at country level. This information is available on request from Supply Division: Contact: supply@unicef.org

General Description:
Nevirapine 50mg dispersible tablets, bottle pack of 30

Technical Specifications:
Each dispersible tablet contains Nevirapine 50mg calculated on the anhydrous basis.
Tablets are used to prepare an oral suspension

Therapeutic class:
Non-nucleoside Reverse Transcriptase Inhibitor (NNRTI)

Standard shelf life:
24 months

Other available formulations:
The product may also be available in other formulations, pack sizes, or in combinations with other ARVs.

Guidelines for use:
For more details, please click the links listed below:

WHO treatment guidelines


WHO Essential Medicines Library

or your regional national guidelines

For details about paediatric dosage schemes, please click the links listed below:


WHO Generic tool for assessing paediatric ARV dosing

Management of HIV infection in combination with at least two other antiretroviral drugs. By mouth (oral), PO.
Prevention of mother-to-child transmission in HIV-infected patients

Do not store above 30ºC (86ºF).
Store in a tightly closed container
Keep out of reach and sight of children.

Dispensing instructions:
Dispense in original container. Do not repack
Tablets are to be dispersed in about 5ml water immediately before administration

Regulatory Status:
For latest updates, please click the links listed below:

List of WHO Prequalified Medicines

List of USFDA approved and tentatively approved items

Related Products